Anti-GPC3 Antibody Tagged Cationic Switchable Lipid-Based Nanoparticles for the Co-Delivery of Anti-miRNA27a And Sorafenib in Liver Cancers
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-GPC3 Antibody Tagged Cationic Switchable Lipid-Based Nanoparticles for the Co-Delivery of Anti-miRNA27a And Sorafenib in Liver Cancers
Authors
Keywords
anti-microRNA27a, apoptosis, lipid nanoparticles, liver cancer, sorafenib
Journal
PHARMACEUTICAL RESEARCH
Volume 36, Issue 10, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-09
DOI
10.1007/s11095-019-2669-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PEGylated polyaminoacid-capped mesoporous silica nanoparticles for mitochondria-targeted delivery of celastrol in solid tumors
- (2018) Ju Yeon Choi et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Impaired Value of 99m Tc-GSA Scintigraphy as an Independent Risk Factor for Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
- (2018) Ikuo Nakamura et al. EUROPEAN SURGICAL RESEARCH
- Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA
- (2018) Rebecca L. Ball et al. NANO LETTERS
- Adipocyte-Derived Exosomal MiR-27a Induces Insulin Resistance in Skeletal Muscle Through Repression of PPARγ
- (2018) Yang Yu et al. Theranostics
- Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review
- (2017) Thiruganesh Ramasamy et al. JOURNAL OF CONTROLLED RELEASE
- Progress towards molecular patient stratification of hepatocellular carcinoma: Lost in translation?
- (2017) Derek Y. Chiang et al. JOURNAL OF HEPATOLOGY
- Cationic switchable lipids: pH-triggered molecular switch for siRNA delivery
- (2017) W. Viricel et al. Nanoscale
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3′UTR
- (2016) Yuan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Development of polymeric irinotecan nanoparticles using a novel lactone preservation strategy
- (2016) Bijay Kumar Poudel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Colloidal Instability Fosters Agglomeration of Subvisible Particles Created by Rupture of Gels of a Monoclonal Antibody Formed at Silicone Oil-Water Interfaces
- (2016) Shyam B. Mehta et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Switchable Lipids: Conformational Change for Fast pH-Triggered Cytoplasmic Delivery
- (2015) Warren Viricel et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- MiR-27a Promotes Hepatocellular Carcinoma Cell Proliferation Through Suppression of its Target Gene Peroxisome Proliferator-activated Receptor γ
- (2015) Xue-Wen Zhang et al. CHINESE MEDICAL JOURNAL
- Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals
- (2015) Baozhen Sun et al. OncoTargets and Therapy
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- Transferrin Modified Graphene Oxide for Glioma-Targeted Drug Delivery: In Vitro and in Vivo Evaluations
- (2013) Guodong Liu et al. ACS Applied Materials & Interfaces
- MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells
- (2013) Zhaolin Chen et al. CELLULAR SIGNALLING
- Expression of Serum miR-16, let-7f, and miR-21 in Patients with Hepatocellular Carcinoma and their Clinical Significances
- (2013) Wei Ge et al. Clinical Laboratory
- Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review of the Literature
- (2013) O. Abdel-Rahman et al. DIGESTIVE DISEASES AND SCIENCES
- Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
- (2012) Mary Maluccio et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sorafenib for the treatment of renal cancer
- (2012) Dirk Strumberg EXPERT OPINION ON PHARMACOTHERAPY
- Nanotechnology applied to overcome tumor drug resistance
- (2012) Zibin Gao et al. JOURNAL OF CONTROLLED RELEASE
- The Role of Glypicans in Wnt Inhibitory Factor-1 Activity and the Structural Basis of Wif1's Effects on Wnt and Hedgehog Signaling
- (2012) Andrei Avanesov et al. PLoS Genetics
- Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
- (2011) Xiaohong Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
- (2011) Kasey C. Vickers et al. NATURE CELL BIOLOGY
- Structure of the protein core of the glypican Dally-like and localization of a region important for hedgehog signaling
- (2011) Min-Sung Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARγ expression
- (2010) Sang Yun Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The role of microRNAs in liver cancer progression
- (2010) S Huang et al. BRITISH JOURNAL OF CANCER
- siRNA delivery systems for cancer treatment
- (2009) Yu-Kyoung Oh et al. ADVANCED DRUG DELIVERY REVIEWS
- New Hope for a MicroRNA Therapy for Liver Cancer
- (2009) John J. Rossi CELL
- Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
- (2009) Hongwei Zhang et al. DIGESTIVE DISEASES AND SCIENCES
- Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
- (2009) Irene K. Guttilla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
- (2009) Antonius A. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors
- (2008) Hironobu Minami et al. CANCER SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started